Coronavirus Infection (COVID-19) and Radical Surgery in Patients With Early-stage Lung Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-11

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to learn about the effects of coronavirus infection in patients with early-stage lung cancer. The main question it aims to answer is whether the interval of surgery and COVID-19 infection will affect the surgery and prognosis of the patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Explore the Optimal Surgical Timing for Lung Surgery and Mediastinal Surgery After COVID-19 Infection

NCT05827328

Thoracic Diseases Thoracic Surgery

COMPLETED

Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery

NCT06483698

Lung Cancer

RECRUITING

Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC

NCT04945928

Pulmonary Neoplasm Advanced Cancer Locally Advanced Cancer

ACTIVE_NOT_RECRUITING NA

Meaning of Recovery After Lung Cancer Surgery

NCT05453812

Recovery Lung Cancer Surgery

UNKNOWN

Perioperative Treatment Outcomes of Early NSCLC

NCT06610240

NSCLC

ENROLLING_BY_INVITATION

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgery Corona Virus Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

stage I/II lung cancer patients

Patients with stage I/II lung cancer will receive radical surgery.

No intervention

Intervention Type OTHER

Observational study, no intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Observational study, no intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinically diagnosed stage I and stage II lung cancer, who are about to receive wedge resection, segmental resection, sleeve resection, lobectomy, or pneumonectomy under general anaesthesia.
* Volunteer to participate in the study with good compliance. Able to complete the observation and follow-up and have signed the informed consent.
* ASA score: I-III;
* Cardiopulmonary functions meet the requirements of radical operation for lung cancer with normal liver and kidney functions.

Exclusion Criteria

* Neurologic, mental illness or mental disorder which is hard to control, poor compliance, unable to cooperate or describe the treatment response;
* Clinically diagnosed stage III and stage IV lung cancer or patients who received neoadjuvant treatment before surgery;
* Patients developed symptoms alike coronavirus infection but are not confirmed by viral RNA detection by quantitative RT-PCR or antigen testing kits.
* Serious heart, lung, liver and kidney dysfunction and unable to tolerate the operation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No